These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36852148)

  • 1. Efficacy and safety of mycophenolate mofetil in treating immune-related hepatitis induced by immune checkpoint inhibitor use: A retrospective study.
    Kadokawa Y; Inoue S; Tatsumi A; Uchida M; Fujita K; Takagi M; Inoue T; Ohe S; Nakai Y; Otsuka T; Abe Y; Nakabori T; Isei T; Kumagai T; Nishimura K; Ohkawa K
    JGH Open; 2023 Feb; 7(2):87-97. PubMed ID: 36852148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.
    Efe C; Taii HA; Ytting H; Aehling N; Bhanji RA; Hagström H; Purnak T; Muratori L; Werner M; Muratori P; Klintman D; Schiano TD; Montano-Loza AJ; Berg T; Larsen FS; Alkhouri N; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
    Dig Dis Sci; 2018 May; 63(5):1348-1354. PubMed ID: 29569003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil for immune checkpoint inhibitor-related hepatotoxicity relapsing during dose reduction of corticosteroid: A report of two cases and literature review.
    Ueno M; Takabatake H; Hata A; Kayahara T; Morimoto Y; Notohara K; Mizuno M
    Cancer Rep (Hoboken); 2022 Sep; 5(9):e1624. PubMed ID: 35575047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mycophenolate mofetil for the treatment of autoimmune hepatitis-an observational study.
    Jothimani D; Cramp ME; Cross TJ
    J Clin Exp Hepatol; 2014 Sep; 4(3):221-5. PubMed ID: 25755564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of mycophenolate mofetil
    Dalekos GN; Arvaniti P; Gatselis NK; Gabeta S; Samakidou A; Giannoulis G; Rigopoulou E; Koukoulis GK; Zachou K
    JHEP Rep; 2022 Dec; 4(12):100601. PubMed ID: 36411768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroid-resistant immune-related adverse events: a systematic review.
    Daetwyler E; Wallrabenstein T; König D; Cappelli LC; Naidoo J; Zippelius A; Läubli H
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38233099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective treatment of steroid-resistant immune checkpoint inhibitor pneumonitis with mycophenolate mofetil.
    Shioiri N; Kikuchi R; Matsumoto I; Furukawa K; Kobayashi K; Abe S
    Respirol Case Rep; 2024 Apr; 12(4):e01356. PubMed ID: 38623524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil as second line treatment in autoimmune hepatitis - A retrospective single center analysis.
    Kolev M; Diem S; Diem L; Rodrigues SG; Berzigotti A; Stirnimann G; Semmo N
    J Transl Autoimmun; 2022; 5():100172. PubMed ID: 36451933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil alongside high-dose corticosteroids: optimizing the management of combination immune checkpoint inhibitor-induced colitis.
    Mir R; Shaw HM; Nathan PD
    Melanoma Res; 2019 Feb; 29(1):102-106. PubMed ID: 30395075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis.
    Efe C; Hagström H; Ytting H; Bhanji RA; Müller NF; Wang Q; Purnak T; Muratori L; Werner M; Marschall HU; Muratori P; Gunşar F; Klintman D; Parés A; Heurgué-Berlot A; Schiano TD; Cengiz M; May-Sien Tana M; Ma X; Montano-Loza AJ; Berg T; Verma S; Larsen FS; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1950-1956.e1. PubMed ID: 28603052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil, azathioprine and methotrexate usage in paediatric anti-NMDAR encephalitis: A systematic literature review.
    Nosadini M; Mohammad SS; Toldo I; Sartori S; Dale RC
    Eur J Paediatr Neurol; 2019 Jan; 23(1):7-18. PubMed ID: 30318435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.
    Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G;
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):268-277. PubMed ID: 29050991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of canine meningoencephalomyelitis of unknown aetiology with mycophenolate mofetil and corticosteroids: 25 cases (2007-2012).
    Woolcock AD; Wang A; Haley A; Kent M; Creevy KE; Platt SR
    Vet Med Sci; 2016 May; 2(2):125-135. PubMed ID: 29067186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil in paediatric autoimmune or immune-mediated diseases of the central nervous system: clinical experience and recommendations.
    Nosadini M; Gadian J; Lim M; Sartori S; Thomas T; Dale RC
    Dev Med Child Neurol; 2019 Apr; 61(4):458-468. PubMed ID: 30221751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil as a successful treatment of corticosteroid-resistant immune checkpoint inhibitor-induced hepatitis.
    Nakano K; Nishizawa M; Fukuda N; Urasaki T; Wang X; Mitani H; Takahashi S
    Oxf Med Case Reports; 2020 Apr; 2020(4):omaa027. PubMed ID: 32477577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study.
    Sukanjanapong S; Thongtan D; Kanokrungsee S; Suchonwanit P; Chanprapaph K
    Dermatol Ther (Heidelb); 2020 Feb; 10(1):179-189. PubMed ID: 31865535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
    Ahsan N; Johnson C; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2001 Jul; 72(2):245-50. PubMed ID: 11477347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study.
    Brill AK; Ott SR; Geiser T
    Respiration; 2013; 86(5):376-83. PubMed ID: 23295253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.